CRIS
Curis Inc
Price:  
0.53 
USD
Volume:  
353,948.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CRIS EV/EBITDA

-2808.0%
Upside

As of 2026-04-07, the EV/EBITDA ratio of Curis Inc (CRIS) is -0.50. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CRIS's latest enterprise value is 17.41 mil USD. CRIS's TTM EBITDA according to its financial statements is -34.92 mil USD. Dividing these 2 quantities gives us the above CRIS EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 14.4x - 18.1x 16.2x
Forward P/E multiples 18.0x - 19.9x 19.0x
Fair Price (14.79) - (14.90) (14.43)
Upside -2874.0% - -2895.8% -2808.0%
0.53 USD
Stock Price
(14.43) USD
Fair Price

CRIS EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-04-06 -0.50
2026-04-02 -0.52
2026-04-01 -0.50
2026-03-31 -0.52
2026-03-30 -0.47
2026-03-27 -0.53
2026-03-26 -0.56
2026-03-25 -0.70
2026-03-24 -0.72
2026-03-23 -0.75
2026-03-20 -0.79
2026-03-19 -0.77
2026-03-18 -0.84
2026-03-17 -0.93
2026-03-16 -0.89
2026-03-13 -1.00
2026-03-12 -1.07
2026-03-11 -1.07
2026-03-10 -1.07
2026-03-09 -1.10
2026-03-06 -1.05
2026-03-05 -1.09
2026-03-04 -1.10
2026-03-03 -1.05
2026-03-02 -1.16
2026-02-27 -1.23
2026-02-26 -1.20
2026-02-25 -1.16
2026-02-24 -1.16
2026-02-23 -1.17
2026-02-20 -1.20
2026-02-19 -1.23
2026-02-18 -1.16
2026-02-17 -1.14
2026-02-13 -1.24
2026-02-12 -1.16
2026-02-11 -1.14
2026-02-10 -1.06
2026-02-09 -1.02
2026-02-06 -1.10
2026-02-05 -0.95
2026-02-04 -1.00
2026-02-03 -0.91
2026-02-02 -0.91
2026-01-30 -0.94
2026-01-29 -0.95
2026-01-28 -0.96
2026-01-27 -1.00
2026-01-26 -0.97
2026-01-23 -0.99